SOLV or HQY: Which Is the Better Value Stock Right Now?

Investors interested in Medical Services stocks are likely familiar with Solventum (SOLV) and HealthEquity (HQY). But which of these two stocks offers value investors a better bang for their buck right now?

Zacks Investment Research • May 15, 2026

Solventum Corporation (SOLV) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Solventum Corporation (SOLV) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Seeking Alpha • May 13, 2026

Solventum (SOLV) Recently Broke Out Above the 200-Day Moving Average

Solventum (SOLV) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, SOLV broke through the 200-day moving average, which suggests a long-term bullish trend.

Zacks Investment Research • May 12, 2026

Solventum to Participate in the 2026 BofA Securities Health Care Conference

ST. PAUL, Minn., May 7, 2026 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today that management will participate in a fireside chat at the BofA Securities Health Care Conference on Wednesday, May 13, 2026, beginning at approximately 10:00 a.m.

PRNewsWire • May 7, 2026

Why Solventum (SOLV) is a Top Momentum Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks Investment Research • May 7, 2026

Solventum Stock Down Despite Q1 Earnings & Revenues Beat Estimates

SOLV beats Q1 earnings and revenue estimates as growth in MedSurg, Dental and HIS offset sales decline and margin pressure.

Zacks Investment Research • May 6, 2026

Solventum (SOLV) Recently Broke Out Above the 20-Day Moving Average

Solventum (SOLV) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, SOLV broke through the 20-day moving average, which suggests a short-term bullish trend.

Zacks Investment Research • May 6, 2026

Solventum (SOLV) Recently Broke Out Above the 50-Day Moving Average

From a technical perspective, Solventum (SOLV) is looking like an interesting pick, as it just reached a key level of support. SOLV recently overtook the 50-day moving average, and this suggests a short-term bullish trend.

Zacks Investment Research • May 6, 2026

Solventum forecasts annual profit at higher end on wound care demand

Medical device maker Solventum said on Tuesday it expects annual profit to be at the higher ​end of its previous forecast range, primarily driven ‌by strong demand for its wound care and sterilization products.

Reuters • May 5, 2026

Solventum Corporation (SOLV) Q1 2026 Earnings Call Transcript

Solventum Corporation (SOLV) Q1 2026 Earnings Call Transcript

Seeking Alpha • May 6, 2026